Literature DB >> 11706655

The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan.

R E Omer1, P Van't Veer, A M Kadaru, E Kampman, I M el Khidir, S S Fedail, F J Kok.   

Abstract

In Sudan, the incidence of hepatocellular carcinoma (HCC) is high and increasing. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are important risk factors of HCC. This study aims to assess the role of HBV and HCV infections in the incidence of HCC in 2 regions of Sudan. A case-control study was conducted in 1996-98 among 150 HCC patients and 205 controls from 2 regions in Sudan. Their demographic characteristics as well as food habits and chronic conditions have been investigated. In this study, 115 cases and 199 controls were tested for hepatitis B surface antigen (HBsAg) and for HCV antibodies. Strong positive associations were found between HBV or HCV, and HCC with odds ratios (ORs) 9.8 (95% CI 5.1-18.9) and 8.3 (95% CI 2.3-29.9), respectively. After adjustment for age, by logistic regression, the ORs for HBV and HCV were 16.1 (95% CI 7.4-34.9) and 4.5 (95% CI 1.1-18.6), respectively. Further adjustment for region, education level and job type did not appreciably affect the results. Given a prevalence of HBV and HCV of 7.0% and 1.5% among controls, about 57% of all HCC cases can be attributed to these viral infections. Hepatitis infections seem to be important risk factors for HCC in Sudan.

Entities:  

Mesh:

Year:  2001        PMID: 11706655     DOI: 10.1016/s0035-9203(01)90013-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan.

Authors:  Shaza Mahgoub; Daniel Candotti; Magdy El Ekiaby; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

2.  Epidemiology of viral hepatitis in Sudan.

Authors:  Hatim My Mudawi
Journal:  Clin Exp Gastroenterol       Date:  2008-12-11

Review 3.  Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis.

Authors:  Karima Chaabna; Silva P Kouyoumjian; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

4.  Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan.

Authors:  Mustafa Abdalla Ali Abou; Yassir Mohammed Eltahir; Abdelwahid Saeed Ali
Journal:  Virol J       Date:  2009-09-23       Impact factor: 4.099

Review 5.  Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Authors:  Seyed Moayed Alavian; Hossein Haghbin
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

6.  A Diagnostic Laboratory-Based Study on Frequency and Distribution of Viral Hepatitis B and C Among Sudanese.

Authors:  Marwan M Badawi; Alshaimaa A Mohammed; Mohammed S Mohammed; Mohammed M Saeed; Elmoez Y Ali; Ashraf Khalil
Journal:  Open Virol J       Date:  2017-10-31

7.  Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.

Authors:  Donatien Serge Mbaga; Sebastien Kenmoe; Cyprien Kengne-Ndé; Jean Thierry Ebogo-Belobo; Gadji Mahamat; Joseph Rodrigue Foe-Essomba; Marie Amougou-Atsama; Serges Tchatchouang; Inès Nyebe; Alfloditte Flore Feudjio; Ginette Irma Kame-Ngasse; Jeannette Nina Magoudjou-Pekam; Lorraine K M Fokou; Dowbiss Meta-Djomsi; Martin Maïdadi-Foudi; Sabine Aimee Touangnou-Chamda; Audrey Gaelle Daha-Tchoffo; Abdel Aziz Selly-Ngaloumo; Rachel Audrey Nayang-Mundo; Jacqueline Félicité Yéngué; Jean Bosco Taya-Fokou; Raoul Kenfack-Momo; Efietngab Atembeh Noura; Cynthia Paola Demeni Emoh; Hervé Raoul Tazokong; Arnol Bowo-Ngandji; Carole Stéphanie Sake; Etienne Atenguena Okobalemba; Jacky Njiki Bikoi; Richard Njouom; Sara Honorine Riwom Essama
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.